mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |